| High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy L Gonzalez-Malerva, J Park, L Zou, Y Hu, Z Moradpour, J Pearlberg, ... Proceedings of the National Academy of Sciences 108 (5), 2058-2063, 2011 | 123 | 2011 |
| In situ drug-receptor binding kinetics in single cells: a quantitative label-free study of anti-tumor drug resistance W Wang, L Yin, L Gonzalez-Malerva, S Wang, X Yu, S Eaton, S Zhang, ... Scientific reports 4 (1), 6609, 2014 | 47 | 2014 |
| Ibrutinib inhibition of ERBB4 reduces cell growth in a WNT5A-dependent manner F Rauf, F Festa, JG Park, M Magee, S Eaton, C Rinaldi, CM Betanzos, ... Oncogene 37 (17), 2237-2250, 2018 | 46 | 2018 |
| Actin expression in Taenia solium cysticerci (cestoda): tisular distribution and detection of isoforms JR Ambrosio, O Reynoso-Ducoing, H Hernández-Sanchez, ... Cell Biology International 27 (9), 727-733, 2003 | 25 | 2003 |
| Kinome-level screening identifies inhibition of polo-like kinase-1 (PLK1) as a target for enhancing non-viral transgene expression MD Christensen, JJ Elmer, S Eaton, L Gonzalez-Malerva, J LaBaer, ... Journal of controlled release 204, 20-29, 2015 | 20 | 2015 |
| Muscular myosin isoforms of Taenia solium (Cestoda) L Gonzalez‐Malerva, M Cruz‐Rivera, O Reynoso‐Ducoing, C Retamal, ... Cell biology international 28 (12), 885-894, 2004 | 14 | 2004 |
| Abstract P4-05-07: functional genomics of TP53 mutations and its impact in breast cancer progression A Pal, L Gonzalez-Malerva, S Eaton, M Guzman, D Chow, H Yin, J Park, ... Cancer Research 75 (9_Supplement), P4-05-07-P4-05-07, 2015 | 2 | 2015 |
| Autophagy and Tamoxifen Resistance in Breast Cancer. L Gonzalez-Malerva, J Park, L Zou, Y Hu, Z Moradpour, J Pearlberg, ... Cancer Research 69 (24_Supplement), 5135-5135, 2009 | 2 | 2009 |
| Multidimensional quantitative phenotypic and molecular analysis reveals neomorphic behaviors of p53 missense mutants A Pal, L Gonzalez-Malerva, S Eaton, C Xu, Y Zhang, D Grief, L Sakala, ... NPJ Breast Cancer 9 (1), 78, 2023 | 1 | 2023 |
| Germline findings in targeted tumor sequencing using matched normal DNA S Krishnan, G Basu, L Gonzalez-Malerva, T Royce, T White, J LoBello, ... Cancer Res 76 (14 Suppl), 2016 | 1 | 2016 |
| Abstract P5-04-19: JAK2 copy number and targeted JAK2 inhibition of TNBC cell lines M Chen, M Andreozzi, L Gonzalez-Malerva, S Eaton, B Pockaj, MT Barrett, ... Cancer Research 76 (4_Supplement), P5-04-19-P5-04-19, 2016 | 1 | 2016 |
| ARID1A alterations in gastrointestinal cancers and therapeutic opportunities GD Basu, T White, J LoBello, K Lau, ML Syring, S Krishnan, ... Journal of Clinical Oncology 34 (4_suppl), 671-671, 2016 | 1 | 2016 |
| Abstract C299: Functional differences of mutant p53's expressed in MCF10A cells and their contribution to breast carcinogenesis. LG Gonzalez-Malerva, S Eaton, A Pal, D Chow, M Guzman, ... Molecular Cancer Therapeutics 12 (11_Supplement), C299-C299, 2013 | 1 | 2013 |
| Abstract B061: Discovering co-driver genes and pathways of mutant TP53 in breast cancer by CRISPR screening and multi-omics approaches L Nwekwo, A Pal, Y Zheng, L Sakala, L Gonzalez-Malerva, D Grief, ... Cancer Research 84 (3_Supplement_1), B061-B061, 2024 | | 2024 |
| A genome-wide functional genomics screen reveals unique co-driver mutations of mutant TP53 promoting cellular heterogeneity during breast cancer progression D Grief, A Pal, L Gonzalez-Malerva, S Eaton, C Xu, G Christensen, J Blain, ... CANCER RESEARCH 82 (4), 2022 | | 2022 |
| Abstract P1-02-05: A genome-wide functional genomics screen reveals unique co-driver mutations of mutant TP53 promoting cellular heterogeneity during breast … D Grief, A Pal, L Gonzalez-Malerva, S Eaton, C Xu, G Christensen, J Blain, ... Cancer Research 82 (4_Supplement), P1-02-05-P1-02-05, 2022 | | 2022 |
| Abstract P1-08-05: Discovering drug targets for aggressive breast cancer with TP53 missense mutations by a genome-wide screen A Pal, J Park, L Gonzalez-Malerva, S Eaton, J LaBaer Cancer Research 77 (4_Supplement), P1-08-05-P1-08-05, 2017 | | 2017 |
| Targeted tumor sequencing using matched normal DNA to assess mutational load. GD Basu, T White, S Krishnan, L Gonzalez, JR LoBello, KR Lau, M Syring, ... Journal of Clinical Oncology 34 (15_suppl), 11599-11599, 2016 | | 2016 |
| ARID1A alterations in gynecological cancers as a therapeutic opportunity. L Gonzalez-Malerva, GD Basu, M Syring, S Krishnan, T White, JR LoBello, ... Journal of Clinical Oncology 34 (15_suppl), e17044-e17044, 2016 | | 2016 |
| Overcoming cellular barriers for enhancing polymer-mediated transgene expression M Christensen, J Elmer, S Barua, S Eaton, L Gonzalez-Malerva, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016 | | 2016 |
